A health worker shows Covaxin vial during preparation for 15-18 age group vaccination drive in Patna.
Highlights
- Hyderabad-based vaccine manufacturer Bharat Biotech announced that Covaxin is now universal vaccine
- Covaxin can neutralise both Delta, Omicron variants, claimed Bharat Biotech earlier
- Earlier studies also demonstrated neutralizing potential of Covaxin: Bharat Biotech
Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday (January 13) announced that its indigenously developed COVID-19 vaccine Covaxin is now a universal vaccine for adults and children.
"COVAXIN is now a universal vaccine for adults and children. Our goals of developing a global vaccine against COVID-19 have been achieved and all product development for licensure has been completed," said Bharat Biotech.
Earlier, Hyderabad-based Hyderabad-based vaccine manufacturer had claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.
In a statement, Bharat Biotech said, "Results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series of Covaxin, neutralized the SARS-CoV-2 Omicron and Delta variants."
It also mentioned that earlier studies demonstrated the neutralizing potential of Covaxin against SARS-CoV-2 Variants of Concern Alpha, Beta, Delta, Omicron, Zeta and Kappa.
ALSO READ: Covaxin booster dose trial shows 'long-term safety', claims Bharat Biotech
